stockrow
Friday 6 November 2026
Export SOLV’s income statement to Excel — free account
Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.
- Revenue
- −7.01%
- EPS
- −101.0%
- Free cash flow
- +561.9%
- Total debt
- −90.1%
Quarter to September 2026, against a year earlier
86.56
2.79
−3.12%
Follow SOLV
Alert me
Solventum Corporation (SOLV) Debt to equity
Solventum Corporation's debt to equity at the end of the quarter to 30 September 2026 was 0.1×, down 0.9× from fiscal 2025 (1.0×). That is above the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 1.0× | (63.16%) |
| FY2024 | 2.7× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | 0.1× | (90.42%) |
| Jun 2026 | 1.1× | 3.51% |
| Mar 2026 | 1.1× | 6.70% |
| Dec 2025 | 1.0× | (3.21%) |
| 12 more quarters | Free account |
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| ALGN Align Technology, Inc. compare | 0.0× |
| WST West Pharmaceutical Services, Inc. compare | 0.1× |
| SOLV Solventum Corporation | 0.1× |
| RGEN Repligen Corporation compare | 0.3× |
| COO The Cooper Companies, Inc. compare | 0.3× |
| ATR AptarGroup, Inc. compare | 0.5× |
| AVTR Avantor, Inc. compare | 0.6× |
| BLCO Bausch + Lomb Corporation compare | 0.8× |
| BAX Baxter International Inc. compare | 1.3× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement